[1]
F. Fadel, “Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients”, Open Access Maced J Med Sci, vol. 5, no. 2, pp. 222–227, Apr. 2017.